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Abstract
Cholangiocarcinoma is the most common malignant bile duct and the second most common primary malignant tumor
in the liver. It can be classified as intrahepatic (peripheral) or extrahepatic. Extrahepatic cholangiocarcinoma originate
most often from the main hepatic duct and confluence (referred to as Klatskin tumor). The patients usually present
with jaundice because of biliary obstruction. Prognosis of hilar cholangiocarcinoma is poor, because most tumors are
not resectable at the time of diagnosis. Surgical exploration should only be undertaken when there is potential for
curative resection shown by imaging.
ERCP (endoscopic retrograde cholangio-pancreatography) demonstration of Klatskin tumors is often incomplete
due to incomplete ductal filling. MR imaging and helical CT are the methods of choice in the diagnosis and staging of
hilar cholangiocarcinoma. MR cholangiography, in conjunction with MR imaging and MRA, provides information on
tumor size, bile duct involvement, and vascular compromise, and thus resectability of the tumor. Multi-phasic contrast-
enhanced thin-section helical CT may show Klatskin tumors with a sensitivity of up to 100%. Tumors are better seen
on arterial-dominant phase than on portal venous phase scans (sensitivity, 100% vs. 86%). However, single-slice CT
is not accurate for assessing resectability (accuracy, 60%), because proximal tumor extent is largely underestimated.
Preliminary experience with multi-slice CT indicates that the extent of bile duct involvement may be better displayed
due to multi-planar imaging capabilities. Curved planar reconstruction of multi-slice CT data sets along the portal
vein and the bile ducts reveals tumor involvement.
Intrahepatic cholangiocarcinoma have a non-specific imaging appearance. Because of abundant fibrous stroma, they
exhibit little contrast enhancement during CT or MR imaging scanning in the early phase with delayed accumulation
of contrast material. Although not pathognomonic, the presence of bile duct dilatation within the tumor and retraction
of the liver capsule adjacent to the tumor are suggestive of the diagnosis.
In conclusion, the role of contrast-enhanced MR imaging with MR cholangiography and multi-slice CT in the
detection and preoperative staging of cholangiocarcinoma is emphasised.
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Classification of bile duct malignancies
Biliary duct tumors are uncommon, with cholangio-
carcinoma being by far the most common. Cholangio-
carcinoma arise from any portion of the intrahepatic
or extrahepatic bile duct epithelium. Accordingly, they
are classified as intrahepatic (peripheral) cholangiocarci-
noma or extrahepatic cholangiocarcinoma. They usually
become clinically apparent because of progressive biliary
obstruction. Intrahepatic cholangiocarcinoma are the
second most common primary malignancy of the liver.
Extrahepatic cholangiocarcinomata originate most often
from the main hepatic duct and confluence (often
referred to as Klatskin tumor). Rarely, extrahepatic
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cholangiocarcinoma originate from the distal common
bile duct, and which are then virtually indistinguishable
from pancreatic tumors by imaging.
Klatskin tumor
Hilar cholangiocarcinoma (Klatskin tumors) are cate-
gorised according to the Bismuth classification [1]: a
type I tumor involves the main hepatic duct below the
bifurcation; a type II tumor affects the main hepatic
duct bifurcation; a type III tumor involves segmental
ducts beyond the primary hepatic duct bifurcation in one
liver lobe (type IIIa: right lobe, type IIIb: left lobe);
type IV tumors involve segmental ducts in both liver
lobes. Prognosis of hilar cholangiocarcinoma is poor,
with few of the tumors being resectable at the time
of diagnosis. Thus, surgical exploration should only be
undertaken when there is potential for curative resection
shown by imaging.
Radiologic evaluation
Diagnosis of Klatskin tumors has been a domain of
ERCP, which may provide demonstration of bile duct
involvement and histologic proof of malignancy. How-
ever, ERCP demonstration of bile duct anatomy is often
incomplete due to incomplete ductal filling in Klatskin
tumors. Sonography is sensitive in detecting biliary
obstruction in these patients, although small tumors
are often not seen. Contrast-enhanced MR imaging
and helical CT have proved useful in the diagnosis
and staging of hilar cholangiocarcinoma. HASTE MR
cholangiography, in conjunction with contrast-enhanced
MR imaging and MRA, allows assessment of tumor
size, bile duct involvement, and vascular compromise,
which is crucial for assessment of resectability of the
tumor [2] (Fig. 1). Multi-phasic contrast-enhanced thin-
section single-slice helical CT may show Klatskin tumors
with a sensitivity of up to 100% [3]. Tumors are better
seen on arterial-dominant phase scans than on portal
venous phase scans (sensitivity 100% vs. 86%). However,
single-slice helical CT is still inaccurate for assessing
resectability (accuracy, 60%), because proximal tumor
extent is largely underestimated. Preliminary experience
with multi-slice CT indicates that tumor extension may be
better displayed due to multi-planar imaging capabilities.
Curved planar reconstructions along the main, right,
and left portal vein and along the intrahepatic bile
ducts show the extent of tumor involvement more
precisely [4]. In contrast to ‘conventional’ axial images,
they reveal a ‘pseudo-surgical’ view of the tumor growth
pattern. Arterial and portal vein anatomy as well as
vascular anomalies relevant for surgery are reliably
depicted by multi-slice CT angiography [5]. Whether
or not 3D reconstructions of multi-slice CT data sets
significantly improve the accuracy of CT in predicting




Peripheral cholangiocarcinoma is a primary adenocar-
cinoma of the liver arising from the epithelium of the
small bile ducts. Histopathologically, the diagnosis is
difficult to differentiate from metastatic adenocarcinoma.
Macroscopically, intrahepatic cholangiocarcinomata are
classified as mass-forming type, periductal-infiltrating
type, and intraductal-growth type [6]. Intrahepatic cholan-
giocarcinoma have a non-specific imaging appearance.
Because of the presence of abundant fibrous stroma, these
tumors most often show little contrast enhancement at CT
or MR imaging scanning in the early phase, but delayed
accumulation of contrast material. Although non-specific
signs, the presence of bile duct dilatation within the tumor
and retraction of the liver capsule adjacent to the tumor
are suggestive of the diagnosis [7].
Radiologic evaluation
Only a few studies have compared the diagnostic yield of
contrast-enhanced CT and MR imaging in the detection
and staging of peripheral cholangiocarcinoma. Choi et al.
reported in a study on 11 patients that MR imaging was
slightly superior to contrast-enhanced dynamic CT in
tumor detection [8]. In a study comparing dynamic CT and
dynamic gadolinium-enhanced MR imaging, Zhang et al.
reported that tumor conspicuity was better in MR imaging
than in CT in 14 of 20 patients. However, dynamic
CT was better than MR imaging for demonstration of
vascular involvement and extrahepatic extension [9]. To
the best of our knowledge, no further studies using state-
of-the art helical or multi-slice CT equipment (Fig. 2) and
MR imaging with liver-specific contrast agents have been
conducted.
Conclusion
In conclusion, detection and accurate staging of Klatskin
tumors is improved by multi-phasic helical CT scanning
and MR imaging. Curved planar reconstructions from
multi-slice CT data sets with thin collimation may further
improve our ability to diagnose vascular involvement.
MR cholangiography, in conjunction with contrast-
enhanced MR imaging, provides 3D images of the biliary
tracts that facilitate planning of surgery or guide palliative
drainage.
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Figure 1 Klatskin tumor. (a) MRCP demonstrates tumor involvement of the hepatic duct bifurcation with
massive intrahepatic bile duct dilatation; (b) Gadolinium-enhanced MRI in the early arterial phase reveals a
small hyperenhancing tumor around the bile duct bifurcation.
(a) (b)
Figure 2 Peripheral cholangiocarcinoma after preoperative chemotherapy. (a) Axial multi-slice CT image
shows a small residual mass in the left lobe with thrombosis of the left hepatic vein. (b) The sagittal MPR of the
3D data set demonstrates much better the residual tumor cuff around the thrombosed left hepatic vein, which
abuts the inferior vena cava. At surgery, the tumor could be resected along the IVC.
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